Overview

Definition:
-Excisional biopsy is a surgical procedure to completely remove a palpable breast mass and a margin of surrounding tissue for histological examination
-It is performed to obtain a definitive diagnosis and to remove benign lesions or to resect malignant tumors, serving both diagnostic and therapeutic purposes.
Epidemiology:
-Palpable breast masses are common in women, with a significant proportion being benign (e.g., fibroadenomas, cysts, fibrocystic changes)
-Malignancy rates in palpable masses vary by age, with higher likelihood in postmenopausal women or those with specific risk factors
-Excisional biopsy is a cornerstone in the evaluation of such masses.
Clinical Significance:
-Accurate diagnosis of a palpable breast mass is critical for appropriate management and patient outcomes
-Excisional biopsy provides definitive histological diagnosis, differentiating benign conditions from breast cancer, thereby guiding further treatment strategies, preventing delayed diagnosis of malignancy, and offering symptomatic relief for benign lesions.

Indications

Indications For Biopsy:
-Suspicion of malignancy based on imaging (mammography, ultrasound, MRI) or clinical examination
-Palpable masses that are persistent, growing, or symptomatic despite initial investigation
-Lesions that cannot be definitively diagnosed by less invasive methods (fine needle aspiration cytology, core needle biopsy)
-Removal of cosmetically significant or symptomatic benign lesions like large fibroadenomas.
Contraindications:
-Absolute contraindications are rare, but severe coagulopathy or systemic illness precluding surgery are relative contraindications
-Local infection at the biopsy site is a contraindication that requires treatment before proceeding.
Preoperative Assessment:
-Thorough clinical history including risk factors for breast cancer, menstrual history, previous breast conditions, and family history
-Comprehensive breast examination to document the size, location, mobility, and characteristics of the mass
-Review of previous imaging studies and pathology reports
-Informed consent must be obtained, explaining the procedure, risks, benefits, and alternatives.

Surgical Procedure

Anesthesia:
-Local anesthesia with or without sedation is commonly used for excisional biopsies of palpable masses
-General anesthesia may be indicated for larger masses, deeper lesions, or in patients who cannot tolerate local anesthesia.
Surgical Technique:
-The incision should ideally follow Langer's lines or be placed in the inframammary fold or areola for cosmetic reasons, depending on the mass location
-The mass is dissected from surrounding tissue, ensuring adequate margins of healthy tissue are included with the specimen
-Hemostasis is meticulously achieved using electrocautery or ligatures
-The specimen is oriented by the surgeon (e.g., by pinning or marking) for accurate margin assessment by pathology.
Specimen Handling:
-The excised specimen is immediately sent to the pathology department
-Crucially, the specimen should be marked or inked to allow the pathologist to assess all margins accurately
-For suspected malignancy, orientation marks (sutures or needles) are essential
-Gross examination by the surgeon before sending to pathology can confirm removal of the palpable lesion.

Postoperative Care

Wound Care:
-The incision is typically closed in layers using absorbable sutures for subcutaneous tissue and non-absorbable or absorbable sutures for skin
-A sterile dressing is applied
-Patients are instructed on wound care, including keeping the area clean and dry, and signs of infection to report.
Pain Management:
-Postoperative pain is usually mild to moderate and managed with oral analgesics like paracetamol or NSAIDs
-Longer-acting local anesthetics may be infiltrated at the time of surgery for sustained pain relief.
Activity Restrictions: Patients are advised to avoid strenuous activity, heavy lifting, and exercises that strain the chest wall for a period of 1-2 weeks to promote healing and minimize complications like seroma formation or wound dehiscitation.
Follow Up:
-Follow-up appointments are scheduled to assess wound healing, remove skin sutures (if non-absorbable), and discuss the final histopathology report
-Further management depends on the diagnosis.

Histopathology And Diagnosis

Importance Of Histology:
-Histopathological examination is the gold standard for definitive diagnosis of a breast mass
-It determines whether the lesion is benign, premalignant, or malignant, and provides crucial information about tumor type, grade, and receptor status for malignant lesions.
Benign Lesions:
-Common benign diagnoses include fibroadenoma, fibrocystic changes, phyllodes tumor, papilloma, adenosis, and fat necrosis
-These often require no further treatment beyond biopsy unless symptomatic or very large.
Malignant Lesions:
-Malignant diagnoses include ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and other rarer types
-If malignancy is found, further surgical management (e.g., lumpectomy with wider margins, mastectomy) and adjuvant therapy will be planned based on the specific cancer characteristics and staging.

Complications

Early Complications:
-Hematoma or seroma formation at the biopsy site
-Wound infection
-Pain and discomfort
-Minor bleeding.
Late Complications:
-Scarring and cosmetic deformity
-Numbness or altered sensation around the scar
-Recurrence of benign lesions if not completely excised
-Psychological distress related to the diagnosis.
Prevention Strategies:
-Meticulous surgical technique with adequate hemostasis
-Proper wound closure and sterile dressing
-Antibiotic prophylaxis in select cases
-Careful patient selection and counseling
-Accurate orientation of the specimen for complete margin assessment.

Key Points

Exam Focus:
-Understanding indications for excisional biopsy vs
-core biopsy
-Importance of specimen orientation and margin assessment
-Histopathological correlation
-Management of common benign and malignant breast lesions identified post-excision
-Differentiating benign from malignant presentations.
Clinical Pearls:
-Always attempt to excise palpable masses, especially if imaging is suspicious or diagnosis is uncertain
-Ensure adequate margins are taken for suspected malignancy
-Communicate clearly with the pathologist about specimen orientation
-Counsel patients on potential scarring and cosmetic outcomes.
Common Mistakes:
-Inadequate margin excision leading to positive margins for malignancy
-Failure to orient the specimen correctly
-Misinterpreting fine needle aspiration (FNA) or core biopsy results as definitive without excisional biopsy when indicated
-Not considering patient's psychological impact of diagnosis and surgery.